Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics
NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.
Original source
Read on DecryptRelated market context
SEC targets 20-year-old rule standing between Wall Street and blockchain trading
The Securities and Exchange Commission (SEC) is moving to dismantle a stock-trading rule that has governed Wall Street for two dec...
Coinbase Council Warns 7 Million Bitcoin May Face Future Quantum Risk
TL;DR Coinbase’s Quantum Advisory Council says post-quantum migration planning should begin before quantum attacks become practica...
GameStop SEC Filing Highlights Coinbase Custody Liquidation Risk For Bitcoin Holdings
TL;DR GameStop’s Form 10-Q includes digital asset custody risk disclosures. The filing discusses circumstances in which a custodia...
Coinbase Quantum Report Warns Millions Of Bitcoin Could Face Future Security Risks
TL;DR Coinbase’s Quantum Advisory Council published a report on post-quantum migration and abandoned coins. The report estimates t...
Coinbase Teases Next Phase of ‘Everything Exchange’ for Crypto, Stocks, Perps
Coinbase is teasing the next phase of its Everything Exchange vision built around one account for crypto, stocks, ETFs, cash, perp...
Kraken Adds USDCx Support On Canton As Institutional Stablecoin Rails Expand
TL;DR Kraken says it now supports USDCx deposits and withdrawals on the Canton Network. USDCx is described as a Canton-native stab...